These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24803328)

  • 1. Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy.
    Ortego-Jurado M; Ríos-Fernández R; Callejas-Rubio JL; Gonzalez-Gay MA; Ortego-Centeno N
    Osteoporos Int; 2014 Aug; 25(8):2157-8. PubMed ID: 24803328
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vitamin D therapy on bone turnover markers in postmenopausal women with osteoporosis and osteopenia.
    Tanzy ME; Camacho PM
    Endocr Pract; 2011; 17(6):873-9. PubMed ID: 21550960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Low Vitamin D Levels Is Ineffective in Postmenopausal Women.
    Shaughnessy AF
    Am Fam Physician; 2016 Feb; 93(4):315. PubMed ID: 26926821
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.
    Ralston SH; Binkley N; Boonen S; Kiel DP; Reginster JY; Roux C; Chen L; Rosenberg E; Santora A;
    Calcif Tissue Int; 2011 Jun; 88(6):485-94. PubMed ID: 21479913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin D deficiency in postmenopausal women receiving osteoporosis therapy].
    Kraljević I; Kastelan D; Gorsić I; Solak M; Giljević Z; Kasović M; Sertić J; Korsić M
    Lijec Vjesn; 2007; 129(8-9):304. PubMed ID: 18198632
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation.
    Grados F; Brazier M; Kamel S; Mathieu M; Hurtebize N; Maamer M; Garabédian M; Sebert JL; Fardellone P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5175-9. PubMed ID: 14602746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
    Nogues X; Servitja S; Peña MJ; Prieto-Alhambra D; Nadal R; Mellibovsky L; Albanell J; Diez-Perez A; Tusquets I
    Maturitas; 2010 Jul; 66(3):291-7. PubMed ID: 20399042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis treatment and 10 years' oestrogen receptor+ breast cancer outcome in postmenopausal women treated with aromatase inhibitors.
    Bouvard B; Chatelais J; Soulié P; Hoppé E; Saulnier P; Capitain O; Mege M; Mesgouez-Nebout N; Jadaud E; Abadie-Lacourtoisie S; Campone M; Legrand E
    Eur J Cancer; 2018 Sep; 101():87-94. PubMed ID: 30036740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cholecystectomy on 25-hydroxyvitamin D levels and bone mineral density in postmenopausal women.
    Polat HB; Beyazal MS
    Arch Osteoporos; 2018 May; 13(1):61. PubMed ID: 29790021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biphosphonates for the prevention of osteoporosis in postmenopausal women with a low bone mass].
    Pelayo M; Agra Y
    Med Clin (Barc); 2004 Mar; 122(8):304-10. PubMed ID: 15030743
    [No Abstract]   [Full Text] [Related]  

  • 12. 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis.
    Peris P; Martínez-Ferrer A; Monegal A; Martínez de Osaba MJ; Muxi A; Guañabens N
    Bone; 2012 Jul; 51(1):54-8. PubMed ID: 22487299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    Chan AS
    N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15250065
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative correlation of high-density lipoprotein-cholesterol and bone mineral density in postmenopausal Iranian women with vitamin D deficiency.
    Maghbooli Z; Khorrami-Nezhad L; Adabi E; Ramezani M; Asadollahpour E; Razi F; Rezanejad M
    Menopause; 2018 Apr; 25(4):458-464. PubMed ID: 29557847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of vitamin D deficiency in postmenopausal high- and low-energy fracture patient.
    Lee JS; Kim JW
    Arch Osteoporos; 2018 Oct; 13(1):109. PubMed ID: 30306272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of osteoporosis management in younger premenopausal women.
    McLendon AN; Woodis CB
    Womens Health (Lond); 2014 Jan; 10(1):59-77. PubMed ID: 24328599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between vitamin D and falls in young postmenopausal women.
    Palacios S
    Menopause; 2016 Mar; 23(3):239-40. PubMed ID: 26818014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osteoporosis therapy in general practice. Which measure should be included?].
    Abendroth K
    MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal osteoporosis.
    Ettinger B
    Curr Ther Endocrinol Metab; 1994; 5():596-600. PubMed ID: 7704802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.